AGI Therapeutics plc's Board of Directors currently comprises five Non-Executive Directors, including a Non-Executive Chairman, and four Executive Directors. These individuals bring a wealth of experience from the pharmaceutical, financial and investment industries. Individual bios can be found by selecting Management and Board in this section of the website.
Medical and scientific advisors
AGI has appointed medical and scientific experts who advise management on a variety of subjects, providing input and insight on therapeutic areas of interest to the company and assisting the company in making informed decisions with regard to the future development of its clinical programmes.
AGI’s medical and scientific advisors are;
Professor Eamonn Quigley (professor of medicine and human
physiology, National University of Ireland, University College Cork),
Dr Philip Schoenfeld (associate professor of medicine, University
of Michigan Medical School),
Dr William Chey, (associate professor of medicine, University
of Michigan Medical School),
Dr William Sandborn (professor of medicine, Division of
Gastroenterology and Hepatology, Mayo Clinic),
Dr Jan Tack (professor of medicine, Division of Gastroenterology,
Katholieke Universiteit Leuven) and,
Professor John Kelly (director of the School of Pharmacy,
Royal College of Surgeons of Ireland)
